News Nautilus Biotechnology, Inc.

Equities

NAUT

US63909J1088

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
2.74 ^USD	+3.79%		+1.86%	-8.36%

Apr. 30	Transcript : Nautilus Biotechnology, Inc., Q1 2024 Earnings Call, Apr 30, 2024
Apr. 30	Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference	May. 23	GL
Transcript : Nautilus Biotechnology, Inc., Q1 2024 Earnings Call, Apr 30, 2024	Apr. 30
Nautilus Biotechnology Reports First Quarter 2024 Financial Results	Apr. 30	GL
Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI
Nautilus Biotechnology : Reports First Quarter 2024 Financial Results - Form 8-K	Apr. 30	PU
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024	Apr. 11	GL
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024	Apr. 11	AQ
Transcript : Nautilus Biotechnology, Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results	Feb. 28	GL
Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference	Feb. 22	GL
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference	Feb. 22	AQ
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	Feb. 07	GL
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award	Nov. 30	GL
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award	Nov. 30	AQ
Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development	Nov. 01	GL
Transcript : Nautilus Biotechnology, Inc., Q3 2023 Earnings Call, Oct 31, 2023	23-10-31
Nautilus Biotechnology Reports Third Quarter 2023 Financial Results	23-10-31	GL
Nautilus Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Nautilus Biotechnology, Inc.

Equities

NAUT

US63909J1088

Summary

Filters